Benzinga's Microcap Movers for Friday October 5, 2012
Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:
Life Partners Holdings
Shares of Life Partners Holdings (NASDAQ: LPHI), the Waco, TX company engaged in the secondary market for life insurance known as “life settlements”, rose 16.14% Friday on 3 times average volume.
On September 26, Life Partners announced that Travis County District Judge Stephen Yelenosky ruled that the life settlement transactions that it facilitates are not securities under Texas law.
Life Partners Holdings closed at $2.59 on Friday.
Shares of Delcath Systems (NASDAQ: DCTH), the New York City pharmaceutical company focused primarily on treatments for liver cancer, rose 13.74% Friday on 4 times average volume.
Delcath is waiting for FDA acceptance of its New Drug Application for CHEMOSAT, which targets unresectable metastatic cutaneous and ocular melanomas of the liver.
Delcath Systems closed at $2.07 on Friday.
Ur-Energy (NYSE: URG), the Littleton, CO junior mining company, rose 6.32% Friday on almost twice average volume.
Ur-Energy announced Friday the receipt of the Record of Decision (ROD) from the Bureau of Land Management (BLM) approving the Plan of Operations for the Company's Lost Creek uranium in-situ recovery (ISR) project in Wyoming, USA. The ROD represents the final regulatory step needed by the Company to initiate construction and production operations at the project site.
Ur-Energy closed at $1.01 on Friday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.